Pfizer and Valneva have announced their intention to proceed with regulatory filings for their Lyme disease vaccine candidate (PF-07307405/VLA15), even... Read more
Category: Uncategorized
Sanofi commits $180M for rights to Kali Therapeutics’ autoimmune candidate
French pharmaceutical giant Sanofi entered into a strategic licensing agreement with California-based Kali Therapeutics to secure exclusive worldwide rights to... Read more
Viatris’ Effexor becomes Japan’s first approved treatment for Generalized Anxiety Disorder
On March 23, 2026, global healthcare company Viatris Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has... Read more
BARDA awards Just – Evotec contract to optimize Filovirus antibody manufacturing
On March 23, 2026, Just – Evotec Biologics announced its selection by the U.S. Biomedical Advanced Research and Development Authority... Read more
Apollo to acquire 37% minority stake in Syntegon to boost North American expansion
On March 23, 2026, CVC Capital Partners (CVC) announced that an investor group led by Apollo-managed funds has agreed to... Read more
Novartis commits $480M to expand manufacturing and R&D in China
On March 23, 2026, Swiss pharma giant Novartis announced plans to invest over 3.3 billion Chinese yuan (approximately $480 million)... Read more
Free vaccination campaign supports vulnerable groups in Central Vietnam
From March 19 to 27, 2026, the Long Chau healthcare system, in collaboration with Abbott Vietnam and local authorities, launched... Read more
Postponement of new food safety regulations to ease trade bottlenecks
In a recent announcement on March 20, 2026, the Government’s Standing Committee decided to further delay the implementation of Decree... Read more
Health sector activates drug supply contingency plans amid international volatility
On March 23, 2026, the Drug Administration of Vietnam (Ministry of Health) issued an urgent dispatch to local regulatory authorities,... Read more








